Labstat is pleased to announce that Willie J. McKinney, Ph.D., D.A.B.T., has joined the company’s Scientific and Strategic Advisory Board (SSAB).

Dr. McKinney’s regulatory and scientific expertise of nicotine and cannabidiol containing products will help guide Labstat in strategy development, internal program conceptualization and internal scientific research.

Dr Willie McKinneyDr. McKinney is the founder and CEO of McKinney Regulatory Science Advisors, LLC, and a Board Certified in Toxicology by the American Board of Toxicology. He works with companies to resolve the complex and dynamic scientific and regulatory challenges associated with preparing new product regulatory submissions. Dr. McKinney has also served on FDA’s Tobacco Product Scientific Advisory Committee (TPSAC) as the non-voting representative of the tobacco manufacturing industry and was on the Advisory Board of the ENDS US 2019 conferences.

Previously, Dr. McKinney served as Vice President, Global Regulatory Affairs for JUUL labs, San Francisco CA and as Vice President, Regulatory Sciences for Altria Client Services, Richmond VA. Dr. McKinney’s regulatory and scientific expertise of nicotine and cannabidiol containing products will help guide Labstat’s strategic development, internal program conceptualization and internal scientific research.

“Bringing onboard someone of Dr. McKinney’s caliber underscores Labstat’s commitment to excellence in testing services. We are excited to welcome him to the team and look forward to leveraging his deep expertise, experience and network in toxicology.”

– Michael Bond, Labstat President

You may also be interested in:

Loading...